SUBSCRIBE
SUBSCRIBE

Rhythm Pharmaceuticals

NEWS
Drug Development
Saniona Cleared to Continue Phase II Prader-Willi Syndrome Treatment Program
Shares of Denmark-based Saniona are up more than 14 percent on the Stockholm Exchange after the company announced it has been cleared to initiate the second part of a mid-stage trial to develop a treatment for adolescents with Prader-Willi Syndrome.
April 26, 2018
 · 
3 min read
 · 
Alex Keown
Real Estate Developers Eye Boston’s South End for
Genetown
Is There a Biotech Bubble Brewing in Boston?
Billions of dollars are being invested in Boston-based life science companies.
March 21, 2018
 · 
2 min read
 · 
Alex Keown
Deals
Pfizer Quietly Takes Additional Stake in This Boston Pharma
Pfizer has increased its stake in Rhythm Pharmaceuticals.
October 19, 2017
 · 
2 min read
 · 
Alex Keown
Deals
Boston Rare Disease Biopharma Rhythm Seeks $115 Million IPO
September 6, 2017
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Boston’s Rhythm Withdraws $86 Million IPO Citing Acquisition Agreement With Actavis
October 30, 2014
 · 
2 min read
Load More
JOBS
IN THE PRESS
Press Releases
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old
December 23, 2024
 · 
10 min read
Press Releases
Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to include Children as Young as 2 Years Old
December 4, 2024
 · 
10 min read
Press Releases
Capital BioVentures Announces Inaugural Cohort for Ottawa Biotech Accelerator Program
December 3, 2024
 · 
6 min read
Press Releases
Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide
November 18, 2024
 · 
13 min read
Press Releases
Rhythm Pharmaceuticals Announces New Employment Inducement Grants - November 13, 2024
November 14, 2024
 · 
7 min read
Press Releases
Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology
November 14, 2024
 · 
9 min read
Press Releases
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
November 6, 2024
 · 
7 min read
Press Releases
Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update
November 5, 2024
 · 
22 min read
Press Releases
Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024
November 4, 2024
 · 
15 min read
Press Releases
Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome
October 24, 2024
 · 
9 min read
Load More